SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.57 -0.04
(-0.05%)

EUR-INR

105.52 0.34
(0.32%)

GBP-INR

120.86 0.52
(0.43%)

JPY-INR

0.57 0.00
(0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

848.3143291

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

38.55

56720.95

EPS(TTM)

Face Value()

Div & Yield %

52.14

0.12

Back

GHCL consolidated net profit declines 31.09% in the September 2025 quarter

Nov 01,2025

Net profit of GHCL declined 31.09% to Rs 106.70 crore in the quarter ended September 2025 as against Rs 154.83 crore during the previous quarter ended September 2024. Sales declined 9.02% to Rs 721.29 crore in the quarter ended September 2025 as against Rs 792.79 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	721.29	792.79	-9
OPM %	21.80	26.61	-
PBDT	172.16	224.18	-23
PBT	144.53	196.33	-26
NP	106.70	154.83	-31

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.57 -0.04 (-0.05%)

105.52 0.34 (0.32%)

120.86 0.52 (0.43%)

0.57 0.00 (0.60%)